GlassScriptPhysician profile
Dennis H Tafflin
NPI 1790739878
$1,444.76
in general payments reported to CMS, 2019-2025
20 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $40.33 · 2021: $149 · 2022: $112 · 2023: $327 · 2024: $384 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $234.31 | 2019-2025 | |
| Amgen INC. | $204.77 | 2023-2025 | Otezla, Krystexxa |
| Biocryst US Sales Co., LLC | $127.49 | 2024 | Orladeyo |
| Phathom Pharmaceuticals, INC. | $121.53 | 2024 | Voquezna |
| Genzyme Corporation | $97.68 | 2024 | |
| Glaxosmithkline, LLC. | $92.56 | 2019-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Sanofi Pasteur INC. | $86.45 | 2019-2022 | |
| Boston Scientific Corporation | $85.14 | 2023 | Watchman Flx |
| Ani Pharmaceuticals, INC. | $82.68 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $75.64 | 2021-2023 | Vraylar |
| Abbott Laboratories | $72.96 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $35.98 | 2019-2022 | |
| Metuchen Pharmaceuticals | $20.44 | 2019 | |
| Exact Sciences Corporation | $19.58 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $19.22 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $16.52 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.28 | 2021 | |
| Mylan Specialty L.P. | $13.78 | 2019 | |
| Amarin Pharma, INC. | $12.73 | 2019 | |
| Philips North America LLC | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Tafflin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.